Julius M. Wilder, Ph.D.

Affiliations: 
2007 Duke University, Durham, NC 
Area:
Demography, Public and Social Welfare, Ethnic and Racial Studies, Black Studies
Google:
"Julius Wilder"

Parents

Sign in to add mentor
Angela M. O'Rand grad student 2007 Duke
 (Socioeconomic status as a fundamental cause of mortality in African Americans: The Pitt County study.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Goldberg D, Wilder J, Terrault N. (2024) Health disparities in cirrhosis care and liver transplantation. Nature Reviews. Gastroenterology & Hepatology
Henson JB, Wilder JM, Kappus MR, et al. (2020) Transplant Outcomes in Older Patients with Nonalcoholic Steatohepatitis Compared to Alcohol-Related Liver Disease and Hepatitis C. Transplantation
Spiritos Z, Salvador S, Mosquera D, et al. (2019) Acute Intermittent Porphyria: Current Perspectives And Case Presentation. Therapeutics and Clinical Risk Management. 15: 1443-1451
Proeschold-Bell RJ, Evon DM, Yao J, et al. (2019) A randomized controlled trial of an integrated alcohol reduction intervention in patients with hepatitis C infection. Hepatology (Baltimore, Md.)
Wilder J, Choi SS, Moylan CA. (2019) Evaluation for Fibrosis After Cure of Hepatitis C-Reply. Jama. 321: 1535
Mosquera DM, Wilder J, Ellis A, et al. (2019) 301. Risk of Virologic Failure with Antiretroviral Switches in HIV/HCV Co-infections Open Forum Infectious Diseases. 6
Wilder J, Choi SS, Moylan CA. (2018) Vibration-Controlled Transient Elastography for Diagnosing Cirrhosis and Staging Hepatic Fibrosis. Jama
Patel YA, Henson JB, Wilder JM, et al. (2018) The impact of human leukocyte antigen donor and recipient serotyping and matching on liver transplant graft failure in primary sclerosing cholangitis, autoimmune hepatitis, and primary biliary cholangitis. Clinical Transplantation. e13388
Proeschold-Bell RJ, Evon DM, Makarushka C, et al. (2018) The Hepatitis C-Alcohol Reduction Treatment (Hep ART) intervention: Study protocol of a multi-center randomized controlled trial. Contemporary Clinical Trials
Clement ME, Collins LF, Wilder JM, et al. (2018) Hepatitis C Virus Elimination in the Human Immunodeficiency Virus-Coinfected Population: Leveraging the Existing Human Immunodeficiency Virus Infrastructure. Infectious Disease Clinics of North America. 32: 407-423
See more...